BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22212555)

  • 1. SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
    Wang C; Uray IP; Mazumdar A; Mayer JA; Brown PH
    Breast Cancer Res Treat; 2012 Jul; 134(1):101-15. PubMed ID: 22212555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
    Wang C; Mayer JA; Mazumdar A; Brown PH
    Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.
    Juraszek B; Nałęcz KA
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
    Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
    Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
    Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.
    Pradhan M; Bembinster LA; Baumgarten SC; Frasor J
    J Biol Chem; 2010 Oct; 285(41):31100-6. PubMed ID: 20705611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.
    Duan R; Ginsburg E; Vonderhaar BK
    Mol Cell Endocrinol; 2008 Jan; 281(1-2):9-18. PubMed ID: 18022314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor.
    Bahadur U; Ganjam GK; Vasudevan N; Kondaiah P
    Mol Cell Endocrinol; 2005 Feb; 231(1-2):1-11. PubMed ID: 15713531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
    Chang M; Peng KW; Kastrati I; Overk CR; Qin ZH; Yao P; Bolton JL; Thatcher GR
    Endocrinology; 2007 Oct; 148(10):4793-802. PubMed ID: 17584965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
    Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase.
    Papierniak-Wyglądała A; Lamch W; Jurewicz E; Nałęcz KA
    Arch Biochem Biophys; 2023 Jul; 742():109616. PubMed ID: 37187422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics.
    Dinarvand N; Karimi F; Azizi R; Rastaghi S; Sheikhi A; Pourfarzam M
    Mol Biol Rep; 2023 Mar; 50(3):2061-2066. PubMed ID: 36539562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
    Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R
    J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
    Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
    Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
    Okura T; Kato S; Deguchi Y
    Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the human, porcine and bovine OCTN2 gene by PPARα via a conserved PPRE located in intron 1.
    Luo H; Zhang Y; Guo H; Zhang L; Li X; Ringseis R; Wen G; Hui D; Liang A; Eder K; He D
    BMC Genet; 2014 Sep; 15():90. PubMed ID: 25299939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promoter of the rat 3-hydroxy-3-methylglutaryl coenzyme A reductase gene contains a tissue-specific estrogen-responsive region.
    Di Croce L; Vicent GP; Pecci A; Bruscalupi G; Trentalance A; Beato M
    Mol Endocrinol; 1999 Aug; 13(8):1225-36. PubMed ID: 10446899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
    Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
    Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.